• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ImageneBio, Inc. - Common Stock (NQ:IMA)

4.600 +0.020 (+0.43%)
Delayed Quote Updated: 3:59 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,832
Open 4.685
Bid (Size) 2.550 (100)
Ask (Size) 5.720 (500)
Prev. Close 4.580
Today's Range 4.557 - 4.685
52wk Range 3.940 - 8.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio to Participate in H.C. Wainwright 28th Annual Global Investment Conference in New York
September 08, 2026
From ImageneBio, Inc.
Via GlobeNewswire

Performance

52-Week Range 48.6% below 52-week high
4.600
3.9452W Low 8.9552W High
1 Week 5.1% below 1-week high
4.561W Low 4.841W High

ImageneBio, Inc. - Common Stock (IMA) traded between $3.94 and $8.95 over the past 52 weeks and last traded at $4.60, 48.6% below its 52-week high. Over the past week it ranged between $4.56 and $4.84.

Past 12 Months
-0.9%
-5.8%
-23.3%
+1.1%
-32.0%
-46.5%
1W -$0.04
1M -$0.29
3M -$1.40
6M +$0.05
YTD -$2.16
1Y -$4.00

IMA was -46.5% over the past year, +1.1% over six months, -32.0% year to date, -0.9% in the last week.

12 Months vs Market
IMA
-46.5%
DIA
+9.3%
SPY
+15.0%
QQQ
+24.3%
IWM
+14.5%

Over the past 12 months IMA returned -46.5% versus DIA (Dow) +9.3%, SPY (S&P 500) +15.0%, QQQ (Nasdaq 100) +24.3% and IWM (Russell 2000) +14.5%.

Volume & Liquidity 0.62× 3-mo avg
Today 7,832 3-mo avg 12.6K
1W
7.7K
1M
16.7K
3M
12.6K
6M
176.6K
YTD
130.0K
1Y
115.6K

IMA most recently traded 7,832 shares against a 3-month average daily volume of 12.6K.

More News

Read More
News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 17, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Second Quarter 2026 Financial Results
August 05, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Appoints Matt Robbins as General Counsel
July 07, 2026
From ImageneBio, Inc.
Via GlobeNewswire
These stocks are gapping in today's session ↗
June 08, 2026
Via Chartmill
News headline image
ImageneBio to Participate in 2026 Jefferies Global Healthcare Conference in New York
May 27, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update
May 07, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ENDRA Life Sciences (NASDAQ: NDRA) Targets Billions With TAEUS® Liver Imaging Technology
April 13, 2026
Via AB Newswire
News headline image
ImageneBio Announces $30 Million Private Placement
April 13, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
March 17, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Company Update
March 10, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio to Participate in Leerink Global Healthcare Conference
February 26, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Appoints Immunology Drug Development Veteran Dr. Ben Porter-Brown as Chief Medical Officer
February 10, 2026
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio Reports Third Quarter 2025 Financial Results and Provides IMG-007 Program Update Following Closing of Reverse Merger, Concurrent Financing, and Strengthening of Management Team
November 12, 2025
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
ImageneBio to Participate in Fourth Quarter 2025 Investor Conferences
November 06, 2025
From ImageneBio, Inc.
Via GlobeNewswire
News headline image
This Albemarle Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday ↗
October 24, 2025
Via Benzinga

Frequently Asked Questions

Is ImageneBio, Inc. - Common Stock publicly traded?
Yes, ImageneBio, Inc. - Common Stock is publicly traded.
What exchange does ImageneBio, Inc. - Common Stock trade on?
ImageneBio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ImageneBio, Inc. - Common Stock?
The ticker symbol for ImageneBio, Inc. - Common Stock is IMA on the Nasdaq Stock Market
What is the current price of ImageneBio, Inc. - Common Stock?
The current price of ImageneBio, Inc. - Common Stock is 4.600
When was ImageneBio, Inc. - Common Stock last traded?
The last trade of ImageneBio, Inc. - Common Stock was at 10/02/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap